Skip to content

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06650462
Enrollment
57
Registered
2024-10-21
Start date
2024-07-02
Completion date
2025-04-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Trust

Keywords

community-led, COVID-19, trust, vaccine hesitancy, peer mentor, community advisory board

Brief summary

The goal of this study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed description

Eligible participants were randomized to intervention or control group. Intervention group participants met virtually with other community member participants in small discussion groups once a week for one hour over the course of 12 weeks. The online discussion groups were led by peer mentor facilitators and supported by a research team member. Discussion topics included current events, COVID-19, and other health related topics. Control group participants did not meet in weekly discussion groups. At approximately the 0 month, 3 month, and 6 month time points, all participants answered online surveys about health related topics. At the 3 month and 6 month time points, all participants were also asked to self-administer a COVID-19 test that investigators provide. Finally, around the fourth month, intervention group participants were invited to an online feedback session with the research team about participants' experiences in the study.

Interventions

Participants engage in weekly community-led small group discussions about health related topics

Sponsors

Old Dominion University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Participants randomly assigned to intervention or control group; repeated measure assessments at 0 months, 3 months, 6 months

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Resident of one of the 9 housing authority agencies * Willing to participate in Zoom meetings and complete online assessments at baseline, 3-month, and 6-month timepoints * Ability to read, speak, and understand English

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Openness to COVID-19 testing0 months, 3 months, 6 monthsThe COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.
COVID-19 Testing Efficacy0 months, 3 months, 6 monthsThe COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.
COVID-19 Trust0 months, 3 months, 6 monthsTwo items assessing (1) trust in the safety of the COVID-19 vaccine, and (2) trust in the efficacy of the COVID-19 vaccine were used to assess participants' trust relating to COVID-19. Each item is rated on a 5-point Likert scale. Higher scores indicate greater trust.
Qualitative feedback4 monthsQualitative feedback will be obtained from participants in a group feedback session

Secondary

MeasureTime frameDescription
COVID-19 Vaccine Hesitancy0 months, 3 months, 6 monthsVaccine Hesitancy was assessed by an item that asked, "Overall, how hesitant about the COVID-19 vaccine would you consider yourself to be?." This question was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey. The item is scored on a 5-point Likert scale, ranging from "1 - not at all hesitant" to "5 = very hesitant." Higher scores indicate greater hesitancy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKelli J England, PhD

Old Dominion University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026